Weycker, Derek <br/><br/>
Retrospective study of the costs of care during the first year of therapy with etanercept or infliximab among patients aged > or =65 years with rheumatoid arthritis.  [electronic resource] 

 -  Clinical therapeutics  May 2005 
 - 646-56 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0149-2918 
<br/><br/><label>Standard No.: </label>10.1016/s0149-2918(05)00090-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--economics<br/>Antirheumatic Agents--economics<br/>Arthritis, Rheumatoid--drug therapy<br/>Cohort Studies<br/>Drug Therapy, Combination<br/>Etanercept<br/>Female<br/>Health Care Costs<br/>Humans<br/>Immunoglobulin G--economics<br/>Infliximab<br/>Insurance Coverage<br/>Insurance, Health<br/>Male<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Retrospective Studies<br/>Treatment Outcome